Literature DB >> 12687890

Review: clinical variability and genetic heterogeneity in multiple epiphyseal dysplasia.

Kathryn L Chapman1, Michael D Briggs, Geert R Mortier.   

Abstract

This review reports on multiple epiphyseal dysplasia (MED), first described clinically in the early part of the 20th century. Over 50 years later, we are now beginning to unravel the mystery behind the genetic mutations involved in triggering the changes in cartilage observed in this condition. In the past decade considerable progress has been made in identifying the underlying genetic defect in some forms of MED. Understanding the precise effect that these molecular changes have on the integrity of the cartilage extracellular matrix will lead the way in identifying the complex disease pathophysiology that defines MED. In addition, a greater understanding of the role and interactions of specific cartilage molecules may reveal the basis of more widespread cartilage disorders such as osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687890     DOI: 10.1080/pdp.22.1.53.75

Source DB:  PubMed          Journal:  Pediatr Pathol Mol Med        ISSN: 1522-7952


  9 in total

1.  Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis.

Authors:  Louise van der Weyden; Lei Wei; Junming Luo; Xu Yang; David E Birk; David J Adams; Allan Bradley; Qian Chen
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Exome sequencing reveals a novel COL2A1 mutation implicated in multiple epiphyseal dysplasia.

Authors:  Vinod Dasa; James R B Eastwood; Michal Podgorski; Heewon Park; Christopher Blackstock; Tetyana Antoshchenko; Piotr Rogala; Tadeusz Bieganski; S Michal Jazwinski; Malwina Czarny-Ratajczak
Journal:  Am J Med Genet A       Date:  2019-02-10       Impact factor: 2.802

3.  Intrafamilial phenotypic diversity in multiple epiphyseal dysplasia associated with a COL9A2 mutation (EDM2).

Authors:  Mitsuhiko Takahashi; Yoshito Matsui; Tomohiro Goto; Gen Nishimura; Shiro Ikegawa; Hirofumi Ohashi; Natsuo Yasui
Journal:  Clin Rheumatol       Date:  2006-01-27       Impact factor: 2.980

4.  Multiple epiphyseal dysplasia.

Authors:  Johanna Dahlqvist; Hanna Orlén; Hans Matsson; Niklas Dahl; Torsten Lönnerholm; Karl-Henrik Gustavson
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

5.  Skeletal dysplasias associated with mild myopathy-a clinical and molecular review.

Authors:  Katarzyna A Piróg; Michael D Briggs
Journal:  J Biomed Biotechnol       Date:  2010-05-24

6.  Mild myopathy is associated with COMP but not MATN3 mutations in mouse models of genetic skeletal diseases.

Authors:  Katarzyna A Piróg; Yoshihisa Katakura; Aleksandr Mironov; Michael D Briggs
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 7.  Genetic Disorders of the Extracellular Matrix.

Authors:  Shireen R Lamandé; John F Bateman
Journal:  Anat Rec (Hoboken)       Date:  2019-03-06       Impact factor: 2.064

8.  XBP1 signalling is essential for alleviating mutant protein aggregation in ER-stress related skeletal disease.

Authors:  Katarzyna A Piróg; Ella P Dennis; Claire L Hartley; Robert M Jackson; Jamie Soul; Jean-Marc Schwartz; John F Bateman; Raymond P Boot-Handford; Michael D Briggs
Journal:  PLoS Genet       Date:  2019-07-01       Impact factor: 5.917

9.  Abnormal chondrocyte apoptosis in the cartilage growth plate is influenced by genetic background and deletion of CHOP in a targeted mouse model of pseudoachondroplasia.

Authors:  Katarzyna A Piróg; Andreja Irman; Siobhan Young; Poonam Halai; Peter A Bell; Raymond P Boot-Handford; Michael D Briggs
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.